Cancer Family
Osteogenic Neoplasm
CI-CAN-00000304Explore in graph →
Non-malignant101 active trials6 approved drugs8 evidence items
- NCIt
- C6603
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000304Explore in graph →
Clinical trials
357 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00330421 | Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07) | completed | Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2014 | clinicaltrials |
| NCT01216826 | Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Osteosarcoma | unknown | Phase 2 | 20 | Sidnei EpelmanOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00004078 |
| Irinotecan in Treating Children With Refractory Solid Tumors |
| completed |
| Phase 2 |
| 181 |
| Children's Oncology GroupNETWORK |
| 1 |
| Jun 14, 2013 |
| clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00889057 | Sorafenib in Relapsed High Grade Osteosarcoma | completed | Phase 2 | 35 | Italian Sarcoma GroupNETWORK | 1 | Mar 28, 2013 | clinicaltrials |
| NCT00023998 | Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma | completed | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00504140 | Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma | completed | Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00523419 | Chemotherapy for Patients With Osteosarcoma | completed | Phase 2 | 32 | Eli Lilly and CompanyINDUSTRY | 5 | Jun 28, 2011 | clinicaltrials |
| NCT00689195 | Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma(OSCAT) | unknown | Phase 1 / Phase 2 | 24 | Tata Memorial HospitalOTHER_GOV | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00691236 | Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma(ZOL) | unknown | Phase 2 / Phase 3 | 60 | Tata Memorial HospitalOTHER_GOV | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00145639 | Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma | completed | Phase 2 | 80 | St. Jude Children's Research HospitalOTHER | 2 | Jun 10, 2011 | clinicaltrials |
| NCT00572130 | Phase II Study of Intravenous Rexin-G in Osteosarcoma | completed | Phase 2 | 22 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00520936 | A Study of Pemetrexed in Children With Recurrent Cancer | completed | Phase 2 | 72 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 25, 2011 | clinicaltrials |
| NCT00187109 | Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy | completed | Phase 1 / Phase 2 | 40 | St. Jude Children's Research HospitalOTHER | 1 | Apr 10, 2008 | clinicaltrials |
| NCT00180947 | Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse | unknown | Phase 2 | 210 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
Data updated 23 days agoSource updated Apr 30, 2014source: clinicaltrials